http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8607089-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
filingDate 1986-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dcdcbc2eb4fa51911187b069dd1bd35
publicationDate 1986-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8607089-A1
titleOfInvention Murine hybridoma lym-2 and diagnostic antibody produced thereby
abstract Hybridoma Lym-2 (ATCC No. HB 8613) produces murine IgG1 monoclonal antobodies specifically against normal human B cells and derived malignancies. The Lym-2 antibodies have possible clinical utility for the in vivo diagnosis and therapy of human B-cell lymphomas and leukemias.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0316462-A1
priorityDate 1985-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500

Total number of triples: 24.